Freedom Of Access Act Response From The State of Maine
In June 2019, the governor of Maine signed into law LD 1272, a bill that would allow the state to establish a wholesale Canadian prescription drug importation program. On April 13, 2020, the Partnership for Safe Medicines (PSM) filed a request to receive copies of all submitted responses to Maine’s Request for Comment (RFC) for the proposed wholesale prescription drug importation program under the state’s Freedom of Access Act. Several days later, PSM received an email with the requested information. Below is a detailed list of the responses.
Email responses were received from:
Emails with attached comments were received from: